H35.14 Retinopathy of prematurity, stage 3

Name of the Condition

• Retinopathy of prematurity, stage 3

Summary

Retinopathy of prematurity (ROP) is a disorder affecting premature infants, characterized by abnormal blood vessel development in the retina. Stage 3 represents a more advanced phase where abnormal blood vessels grow and partially detach the retina. This stage carries a higher risk of progression to severe vision loss if untreated, requiring prompt evaluation and intervention.

Causes

ROP is caused by the incomplete growth of retinal blood vessels in premature infants. The retina, which normally develops blood vessels by full-term birth, may not have fully vascularized in preterm infants. Factors such as oxygen therapy, fluctuations in oxygen levels, and the infant's overall immaturity contribute to abnormal vessel growth, with stage 3 reflecting significant retinal changes.

Risk Factors

• Prematurity (especially infants born before 31 weeks of gestation).
• Low birth weight (typically under 1500 grams).
• Oxygen therapy or fluctuations in oxygen levels during neonatal care.
• Multiple births (e.g., twins or triplets).
• Certain medical conditions affecting oxygen delivery or retinal development.

Symptoms

In stage 3, ROP may not present obvious symptoms in infants. Severe cases can lead to abnormal eye movements, a white appearance of the pupil (leukocoria), or vision impairment as the child grows. Infants with this stage are typically asymptomatic, and diagnosis relies on routine screening.

Diagnosis

Diagnosis is made through dilated eye examinations using indirect ophthalmoscopy, typically performed by a pediatric ophthalmologist. The examination assesses retinal vascularization, the presence of abnormal blood vessels, and the extent of retinal detachment. Staging follows standardized criteria to determine disease severity.

Treatment Options

Treatment depends on the severity and extent of the condition. Options may include laser therapy, cryotherapy, or anti-VEGF injections to halt abnormal vessel growth. In advanced cases, surgical intervention may be required to reattach the retina. Close monitoring is essential to guide management.

Prognosis and Follow-Up

Prognosis varies based on disease severity and response to treatment. Stage 3 ROP may progress to more severe stages if untreated, potentially leading to vision loss or blindness. Regular follow-up examinations are critical to monitor for regression, progression, or complications.

Complications

Complications can include retinal detachment, macular scarring, strabismus, amblyopia, or blindness. Long-term visual impairment may affect learning and development. Early intervention reduces but does not eliminate these risks.

Lifestyle & Prevention

Prevention focuses on optimizing neonatal care, including careful oxygen management and monitoring of premature infants. No specific lifestyle modifications apply to infants, but parental education on follow-up care is important.

When to Seek Professional Help

Seek immediate evaluation if signs of severe ROP are suspected, such as abnormal eye movements or leukocoria. Routine screening is recommended for all premature infants, with referrals to a pediatric ophthalmologist for abnormal findings.

Tips for Medical Coders

Document the specific stage of ROP (stage 3) and any associated findings, such as retinal detachment or treatment interventions. Ensure documentation supports the clinical severity and guides appropriate coding. Note that stage 3 indicates significant retinal changes requiring careful assessment.